Explores intussusception risk post SARS-CoV-2 and adenovirus infections in children, suggesting heightened vigilance is essential.
Objective To investigate the short-term risk of intussusception following SARS-CoV-2 and adenovirus infections in children Study design Using Japan's health insurance claims database from January 2015 to December 2022, a self-controlled risk interval (SCRI) design and a nested case-control (NCC) analysis with conditional logistic regression were employed to adjust for individual confounders and assess the robustness of the findings. Results The study included 3.6 million children aged <10 years, with 1,069 intussusception events identified by procedure codes. The SCRI analysis revealed a 4-fold increased incidence of intussusception within 0-1 months of SARS-CoV-2 infection (IRR 4.27, 95% CI 2.11-8.67) and a 6-fold increased incidence for adenovirus infection (IRR 6.09, 95% CI 3.18-11.66). The NCC analysis yielded consistent results, with odds ratios of 4.43 (95% CI 2.94-6.66) for SARS-CoV-2 and 8.21 (95% CI 6.12-11.02) for adenovirus. Monte Carlo resampling confirmed the stability of the estimates. Negative control windows showed no increased risk, supporting the validity of the observed associations. Conclusions This study provides population-scale evidence that both SARS-CoV-2 and adenovirus infections are associated with the risk of pediatric intussusception, with adenovirus demonstrating a stronger effect. The findings have implications for clinical vigilance and understanding the impact of viral infections on gastrointestinal disorders in children.
No takes yet. Share an insight, caveat, or question.
Miyamori et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: